Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03832790 · ClinicalTrials.gov registry record
Sleep, Glycemic Control, and Insulin Resistance in Adolescents With Type 1 Diabetes
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 23
- Enrollment target
NCT03832790 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 23 participants.
The verdict
NCT03832790 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
Despite advancements in care, most adolescents with T1D have higher BMI and significantly higher HbA1c than recommended and are markedly IR, placing them at increased risk for CVD1,2. Thus, alternative approaches to improve and maintain glycemic control, IR, and BMI for adolescents with T1D are urgently needed. This proposal moves beyond the current insulin and carbohydrate counting-focused lifestyle change paradigm to focus on sleep and circadian misalignment, which will allow for identification of new mechanisms that can be directly translated into future intervention and prevention trials. The goal of the current study is to utilize multiple objective measures of sleep duration, timing (actigraphy), and circadian rhythm (melatonin) in adolescents with type 1 diabetes (T1D; N = 40) and examine relationships with glycemic control, IR, vascular health, and BMI. Further, qualitative methodology will be used to identify barriers and facilitators to healthy sleep in adolescents with T1D.
Interventions
- OTHER observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-12-04 |
| Est. Completion | 2023-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03832790
The ClinicalTrials.gov registry entry for NCT03832790 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which observation is the first listed.
NCT03832790 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03832790 about?
NCT03832790 is a clinical study titled "Sleep, Glycemic Control, and Insulin Resistance in Adolescents With Type 1 Diabetes". Despite advancements in care, most adolescents with T1D have higher BMI and significantly higher HbA1c than recommended and are markedly IR, placing them at increased risk for CVD1,2. Thus, alternative approaches to improve and maintain glycemic control, IR, and BMI for adolescents with T1D are urge...
What is the current status of trial NCT03832790?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2019-12-04. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT03832790?
The interventions under investigation include: observation (OTHER).
Who is sponsoring clinical trial NCT03832790?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.